Alternative splicing and cell survival: from tissue homeostasis to disease

[1]  Michael R. Green,et al.  U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3' End Formation. , 2016, Molecular cell.

[2]  R. Lothe,et al.  Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes , 2016, Oncogene.

[3]  C. Harris,et al.  p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration , 2016, Cell Death and Differentiation.

[4]  R. Campbell,et al.  Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth. , 2016, The Journal of clinical investigation.

[5]  Yide Mei,et al.  BECN1s, a short splice variant of BECN1, functions in mitophagy , 2015, Autophagy.

[6]  L. Shkreta,et al.  The RNA Splicing Response to DNA Damage , 2015, Biomolecules.

[7]  E. Volpe,et al.  Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9 , 2015, Oncotarget.

[8]  Johan Lindberg,et al.  The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7 , 2015, Scientific Reports.

[9]  C. Sette,et al.  Splicing Regulation: A Molecular Device to Enhance Cancer Cell Adaptation , 2015, BioMed research international.

[10]  C. Ghigna,et al.  SAM68: Signal Transduction and RNA Metabolism in Human Cancer , 2015, BioMed research international.

[11]  E. Pilozzi,et al.  Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells , 2015, Oncogene.

[12]  S. Tomlins,et al.  Consequence of the tumor-associated conversion to cyclin D1b , 2015, EMBO molecular medicine.

[13]  Maria Fichera,et al.  Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. , 2015, The New England journal of medicine.

[14]  Panagiotis K. Papasaikas,et al.  Genome-wide identification of Fas/CD95 alternative splicing regulators reveals links with iron homeostasis. , 2015, Molecular cell.

[15]  Chris Henderson.  Faculty Opinions recommendation of Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. , 2014 .

[16]  Lorenzo Galluzzi,et al.  Metabolic Control of Autophagy , 2014, Cell.

[17]  L. Kwak,et al.  FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma , 2014, Leukemia.

[18]  C. Sette,et al.  Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5′ splice site selection , 2014, Nucleic acids research.

[19]  Lorenzo Galluzzi,et al.  Metabolic control of cell death , 2014, Science.

[20]  Dan Chen,et al.  The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression. , 2014, Cancer cell.

[21]  M. Ares,et al.  Context-dependent control of alternative splicing by RNA-binding proteins , 2014, Nature Reviews Genetics.

[22]  S. Verjovski-Almeida,et al.  Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis , 2014, Nucleic acids research.

[23]  J. Valcárcel,et al.  Regulation of FAS exon definition and apoptosis by the Ewing sarcoma protein. , 2014, Cell reports.

[24]  J. Xiang,et al.  BaxΔ2 Promotes Apoptosis through Caspase-8 Activation in Microsatellite-Unstable Colon Cancer , 2014, Molecular Cancer Research.

[25]  A. Kornblihtt,et al.  The transcription factor FBI‐1 inhibits SAM68‐mediated BCL‐X alternative splicing and apoptosis , 2014, EMBO reports.

[26]  J. Chen,et al.  Alternative splicing in cancer: implications for biology and therapy , 2014, Oncogene.

[27]  P. Chieffi,et al.  The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival , 2013, Nucleic acids research.

[28]  Jian Zhang,et al.  Misregulation of pre-mRNA alternative splicing in cancer. , 2013, Cancer discovery.

[29]  E. Pilozzi,et al.  Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway , 2013, Oncogene.

[30]  Jun O. Liu,et al.  Arginine68 is an essential residue for the C-terminal cleavage of human Atg8 family proteins , 2013, BMC Cell Biology.

[31]  Andrea Ballabio,et al.  Signals from the lysosome: a control centre for cellular clearance and energy metabolism , 2013, Nature Reviews Molecular Cell Biology.

[32]  Ngoc Thang Vu,et al.  hnRNP U Enhances Caspase-9 Splicing and Is Modulated by AKT-dependent Phosphorylation of hnRNP L* , 2013, The Journal of Biological Chemistry.

[33]  F. Zhan,et al.  NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers. , 2013, Cancer cell.

[34]  P. Johnston,et al.  Prognostic and therapeutic relevance of c‐FLIP in acute myeloid leukaemia , 2013, British journal of haematology.

[35]  D. Ouyang,et al.  Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5 , 2013, Autophagy.

[36]  Y. Hua,et al.  Antisense-based therapy for the treatment of spinal muscular atrophy , 2012, The Journal of cell biology.

[37]  J. Xiang,et al.  BaxΔ2 Is a Novel Bax Isoform Unique to Microsatellite Unstable Tumors* , 2012, The Journal of Biological Chemistry.

[38]  S. T. Eblen.  Regulation of chemoresistance via alternative messenger RNA splicing. , 2012, Biochemical pharmacology.

[39]  S. Ohkura,et al.  Follicular growth and atresia in mammalian ovaries: regulation by survival and death of granulosa cells. , 2012, The Journal of reproduction and development.

[40]  Masaaki Komatsu,et al.  Autophagy: Renovation of Cells and Tissues , 2011, Cell.

[41]  C. Compagnucci,et al.  The RNA recognition motif protein RBM11 is a novel tissue-specific splicing regulator , 2011, Nucleic acids research.

[42]  D. Green,et al.  Mitochondria and the Autophagy–Inflammation–Cell Death Axis in Organismal Aging , 2011, Science.

[43]  C. Sette,et al.  The RNA-binding protein Sam68 is a multifunctional player in human cancer. , 2011, Endocrine-related cancer.

[44]  Amy J. Hawkins,et al.  SRSF1 Regulates the Alternative Splicing of Caspase 9 Via A Novel Intronic Splicing Enhancer Affecting the Chemotherapeutic Sensitivity of Non–Small Cell Lung Cancer Cells , 2011, Molecular Cancer Research.

[45]  Junying Yuan,et al.  Alternative cell death mechanisms in development and beyond. , 2010, Genes & development.

[46]  Y. Mandel-Gutfreund,et al.  Heterogeneous Nuclear Ribonucleoprotein H1/H2-dependent Unsplicing of Thymidine Phosphorylase Results in Anticancer Drug Resistance , 2010, The Journal of Biological Chemistry.

[47]  L. Corcos,et al.  Cotranscriptional exon skipping in the genotoxic stress response , 2010, Nature Structural &Molecular Biology.

[48]  J. Minna,et al.  hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing. , 2010, The Journal of clinical investigation.

[49]  P. Silver,et al.  An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis , 2010, Cell.

[50]  R. Kole,et al.  Anti-tumor activity of splice-switching oligonucleotides , 2010, Nucleic acids research.

[51]  F. Allain,et al.  Structural basis of G-tract recognition and encaging by hnRNP F quasi-RRMs , 2010, Nature Structural &Molecular Biology.

[52]  T. Hyslop,et al.  Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene. , 2010, Cancer research.

[53]  C. Sette,et al.  Genotoxic stress causes the accumulation of the splicing regulator Sam68 in nuclear foci of transcriptionally active chromatin , 2010, Nucleic acids research.

[54]  M. Assanah,et al.  HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer , 2010, Nature.

[55]  Manuel de la Mata,et al.  DNA Damage Regulates Alternative Splicing through Inhibition of RNA Polymerase II Elongation , 2009, Cell.

[56]  A. Levine,et al.  The first 30 years of p53: growing ever more complex , 2009, Nature Reviews Cancer.

[57]  H. Rui,et al.  Cyclin D1 Splice Variants: Polymorphism, Risk, and Isoform-Specific Regulation in Prostate Cancer , 2009, Clinical Cancer Research.

[58]  Jenny G. Parvani,et al.  An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance , 2009, Molecular Cancer Therapeutics.

[59]  Johanne Toutant,et al.  Heterogeneous Nuclear Ribonucleoprotein K Represses the Production of Pro-apoptotic Bcl-xS Splice Isoform , 2009, The Journal of Biological Chemistry.

[60]  C. Will,et al.  The Spliceosome: Design Principles of a Dynamic RNP Machine , 2009, Cell.

[61]  J. Valcárcel,et al.  RBM5/Luca-15/H37 regulates Fas alternative splice site pairing after exon definition. , 2008, Molecular cell.

[62]  L. Shkreta,et al.  Antagonistic Effects of the SRp30c Protein and Cryptic 5 ′ Splice Sites on the Alternative Splicing of the Apoptotic Regulator Bcl-x* , 2008, Journal of Biological Chemistry.

[63]  E. Benz,et al.  Novel Splicing Factor RBM25 Modulates Bcl-x Pre-mRNA 5′ Splice Site Selection , 2008, Molecular and Cellular Biology.

[64]  J. M. Izquierdo.  Hu Antigen R (HuR) Functions as an Alternative Pre-mRNA Splicing Regulator of Fas Apoptosis-promoting Receptor on Exon Definition* , 2008, Journal of Biological Chemistry.

[65]  Sherif Abou Elela,et al.  Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes , 2008, Molecular Cancer Therapeutics.

[66]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[67]  C. Sette,et al.  The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells , 2007, Oncogene.

[68]  C. Chalfant,et al.  The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x , 2007, The Journal of cell biology.

[69]  A. Krainer,et al.  The gene encoding the splicing factor SF2/ASF is a proto-oncogene , 2007, Nature Structural &Molecular Biology.

[70]  J. Valcárcel,et al.  Fas-activated Serine/Threonine Kinase (FAST K) Synergizes with TIA-1/TIAR Proteins to Regulate Fas Alternative Splicing* , 2007, Journal of Biological Chemistry.

[71]  C. Chalfant,et al.  SAP155 Binds to ceramide‐responsive RNA cis‐element 1 and regulates the alternative 5′ splice site selection of Bcl‐x pre‐mRNA , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  K. Knudsen.  The cyclin D1b splice variant: an old oncogene learns new tricks , 2006, Cell Division.

[73]  M. Lenardo,et al.  Genetic disorders of programmed cell death in the immune system. , 2006, Annual review of immunology.

[74]  Robert Castelo,et al.  Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. , 2005, Molecular cell.

[75]  K. Schulze-Osthoff,et al.  Regulation of apoptosis by alternative pre-mRNA splicing. , 2005, Molecular cell.

[76]  B. Chabot,et al.  Heterogeneous Nuclear Ribonucleoprotein F/H Proteins Modulate the Alternative Splicing of the Apoptotic Mediator Bcl-x* , 2005, Journal of Biological Chemistry.

[77]  Xinbin Chen,et al.  ΔNp73β Is Active in Transactivation and Growth Suppression , 2004, Molecular and Cellular Biology.

[78]  D. Black.  Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[79]  J. Mohler,et al.  Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents* , 2002, The Journal of Biological Chemistry.

[80]  J. Valcárcel,et al.  The splicing regulator TIA‐1 interacts with U1‐C to promote U1 snRNP recruitment to 5′ splice sites , 2002, The EMBO journal.

[81]  P. Herrlich,et al.  Signal-dependent regulation of splicing via phosphorylation of Sam68 , 2002, Nature.

[82]  F. Alt,et al.  T Cell Costimulation through CD28 Depends on Induction of the Bcl-xγ Isoform , 2002, The Journal of Experimental Medicine.

[83]  Y. Hannun,et al.  De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma Cells , 2002, The Journal of Biological Chemistry.

[84]  Y. Hannun,et al.  FAS Activation Induces Dephosphorylation of SR Proteins , 2001, The Journal of Biological Chemistry.

[85]  J. Morgan,et al.  A comparison of the expression and properties of Apaf-1 and Apaf-1L 1 1 Published on the World Wide Web on 5 October 2000. , 2000, Brain Research.

[86]  J. Valcárcel,et al.  The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. , 2000, Molecular cell.

[87]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[88]  S. Baker,et al.  The Splicing Factor U1C Represses EWS/FLI-mediated Transactivation* , 2000, The Journal of Biological Chemistry.

[89]  Y. Lazebnik,et al.  Caspase-9 and APAF-1 form an active holoenzyme. , 1999, Genes & development.

[90]  J. Adelman,et al.  The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[91]  D. Seol,et al.  A Caspase-9 Variant Missing the Catalytic Site Is an Endogenous Inhibitor of Apoptosis* , 1999, The Journal of Biological Chemistry.

[92]  D. Green.  Apoptotic Pathways The Roads to Ruin , 1998, Cell.

[93]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[94]  Keisuke Kuida,et al.  Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9 , 1998, Cell.

[95]  J C Reed,et al.  Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype , 1997, Science.

[96]  J. Lawrence,et al.  Mitogen-activated Protein Kinase-independent Pathways Mediate the Effects of Nerve Growth Factor and cAMP on Neuronal Survival* , 1996, The Journal of Biological Chemistry.

[97]  S. Ohta,et al.  An Additional Form of Rat Bcl-x, Bcl-xβ, Generated by an Unspliced RNA, Promotes Apoptosis in Promyeloid Cells* , 1996, The Journal of Biological Chemistry.

[98]  R. Testi,et al.  Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. , 1996, Journal of immunology.

[99]  Sharad Kumar,et al.  ICE-like proteases in apoptosis. , 1995, Trends in biochemical sciences.

[100]  al. et,et al.  Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice , 1995, Science.

[101]  T. Behrens,et al.  Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes. , 1994, Journal of immunology.

[102]  L. Wang,et al.  Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death , 1994, Cell.

[103]  Z. Oltvai,et al.  BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax , 1994, Nature.

[104]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[105]  G. Scott,et al.  A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells , 1993, Molecular and cellular biology.

[106]  Y. Hannun,et al.  Programmed cell death induced by ceramide. , 1993, Science.

[107]  Dale Purves,et al.  Trophic regulation of nerve cell morphology and innervation in the autonomic nervous system , 1988, Nature.

[108]  Samir Guglani.  Death , 1890, The Lancet.

[109]  J. Bargonetti,et al.  Splice variants of MDM2 in oncogenesis. , 2014, Sub-cellular biochemistry.

[110]  Carlos L. Arteaga,et al.  Treatment of HER2-positive breast cancer: current status and future perspectives , 2012, Nature Reviews Clinical Oncology.

[111]  T. Hyslop,et al.  Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68. , 2010, Cancer research.

[112]  Xinbin Chen,et al.  DeltaNp73beta is active in transactivation and growth suppression. , 2004, Molecular and cellular biology.

[113]  F. Alt,et al.  T cell costimulation through CD28 depends on induction of the Bcl-xgamma isoform: analysis of Bcl-xgamma-deficient mice. , 2002, The Journal of experimental medicine.

[114]  Y. Hannun,et al.  FAS Activation Induces Dephosphorylation of SR Proteins DEPENDENCE ON THE DE NOVO GENERATION OF CERAMIDE AND ACTIVATION OF PROTEIN PHOSPHATASE 1* , 2001 .

[115]  R. Oppenheim.  Cell death during development of the nervous system. , 1991, Annual review of neuroscience.